References
- Hanson J. S. Propylthiouracil and hepatitis. Arch. Intern. Med. 1984; 144: 994–996
- Zimmerman J. H. Hepatotoxicity, Appleton‐Century‐Crofts. New York 1978; 458
- Cooper D. S. Antithyroid drugs. N. Engl. J. Med. 1984; 311: 1353–1362
- Rajapakse D. A., Glynn L. E. Macrophage migration inhibition test using guinea pig macrophages and human lymphocytes. Nature 1970; 226: 857–858
- Romadini J. H., Bromberg N., Werner R. S., Tanaka L. M., Rodrigues H. F., Werner M. C., Farah C. S., Reis L. C. Comparison of effects of high and low dosage regimen of antithyroid drugs in the management of Graves' hyperthyroidism. J. Clin. Endocrinol. Metab. 1983; 57: 563–570
- Safani M. M., Tatro D. A., Rudd P. Fatal propylthiouracilinduced hepatitis. Arch. Intern. Med. 1982; 142: 838–839
- Fisher M. G., Nayer H. R., Miller A. Methimazole‐induced jaundice. J.A.M.A. 1973; 223: 1028–1029
- Vasily D. B., Tyler W. B. Propylthiouracil‐induced cutaneous vasculitis: Case presentation and review of the literature. J.A.M.A. 1980; 23: 458–461
- Parker L. N. Hepatitis and propylthiouracil. Ann. Intern. Med. 1975; 82: 228–229
- Kunkel H. G. Immune diseases. Cecil. Textbook of Medicine, J. B. Wyngaarden, L. H. Smith, Jr. W.B. Saunders Co., Philadelphia 1982; 1781, London, Toronto
- Anderson K. E., Kappas A. Hormones and liver function. Diseases of the Liver, L. Schiff. Lippincott Co., Philadelphia 1982; 167